TrialDiabetes, obesity & metabolism2022

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial.

Ulrik Pedersen-Bjergaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.